BPS Tyagi1,2* and Mamatarani Rout3
1Professor, Head of Department of ENT, Colombia Asia Hospital, Ghaziabad, India
2Head of Department of ENT and CEO, Harsh ENT Hospital, Ghaziabad, India
3Consultant, Department of ENT, Harsh ENT Hospital, Ghaziabad, India
*Corresponding Author: BPS Tyagi, Professor, Head of Department of ENT, Colombia Asia Hospital and CEO, Harsh ENT Hospital, Ghaziabad, India.
Received: November 17, 2020; Published: November 30, 2020
A comparative study of effect of Intratympanic Dexamethasone and intratympanic PRP in patients presented to Harsh ENT hospital, Ghaziabad with positive Covid 19, and symptoms like heaviness in ears, vertigo and/or tinnitus, and/or bodyache, and/or hearing loss. There was significant improvement in hearing loss and other otological symptoms in majority of patients with IT PRP compared to IT Dexamethasone.
Keywords: Covid 19; Intratympanic; Dexamethasone; Platelet Rich Plasma
Citation: BPS Tyagi and Mamatarani Rout. “Novel Covid 19 - Associated Otological Symptoms and Role of PRP". Acta Scientific Otolaryngology 2.12 (2020): 63-67.
Copyright: © 2020 BPS Tyagi and Mamatarani Rout. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.